30.   There is no change in India's position on the issues of review of the provisions of Article 27.3(b), relationship between the TRIPS Agreement and the CBD, and protection of traditional knowledge and folklore. However, India would take this opportunity to highlight some of the important points from our last submission. India is an ancient civilization with a rich body of traditional knowledge associated with biological resources. In India's case, this traditional knowledge is both coded, as in the texts of Indian systems of medicine, such as Ayurveda, Unani and Siddha; and non-coded, which exists in the oral undocumented traditions. India is also amongst top 20 identified mega diverse countries in the world. 31.   Countries have adopted various methods to protect traditional knowledge and associated genetic resources at the national level. However, in the absence of an enforceable international regime, such domestic/national regimes on their own cannot address misappropriation of existing knowledge in foreign patent offices and biopiracy. 32.   Therefore, it has been one of our long-standing demand that there should be an international enforceable regime that makes patent offices the checkpoint to contain such misappropriation. As in fact, patents should not be granted for existing traditional knowledge and associated genetic resources, and where traditional knowledge and associated genetic resources form the basis of scientific development, patent applications must disclose source or origin of the resource and disclose whether the access was on mutually agreed terms. The TRIPS/CBD linkage is, therefore, important for developing countries because it seeks to address biopiracy. 33.   India is also of the view that a briefing by the CBD Secretariat on the latest developments in the implementation of the Nagoya Protocol would be very useful for a large majority of the Membership of this Council. India also supports updating of three factual briefs by the Secretariat on these issues.